Work with thought leaders and academic experts in Molecular Medicine

Companies can greatly benefit from working with experts in the field of Molecular Medicine. These researchers possess in-depth knowledge and skills that can contribute to various aspects of a company's operations. They can provide valuable insights and expertise in areas such as drug discovery and development, personalized medicine, genomics, biomarker identification, and therapeutic interventions. By collaborating with Molecular Medicine experts, companies can accelerate their research and development processes, improve the effectiveness of their products and services, and stay at the forefront of scientific advancements. Additionally, these collaborations can lead to the identification of new business opportunities, partnerships, and potential commercialization of scientific discoveries.

Researchers on NotedSource with backgrounds in Molecular Medicine include Dr. Sakshi Kabra Malpani, Dr. Everson A Nunes, Ph.D., Dr. David Siderovski, Ph.D., Regan Hamel, Burcu Vitrinel, Ph.D., Elvira Forte, Aimee Eggler, Ping Luo, and Garrett A. Perchetti, Research Scientist - Virology.

Dr. Sakshi Kabra Malpani

Redmond, Washington, United States of America
Researcher with 10+ years expertise in Organic Chemistry, Solid Waste Management, Heterogeneous Catalysis.
Research Expertise (6)
Renewable Energy, Sustainability and the Environment
Materials Chemistry
Organic Chemistry
Health, Toxicology and Mutagenesis
Pollution
And 1 more
About
Hello, I am Sakshi Kabra Malpani, with 10+ years of experience as a green, organic chemist and lecturer. My overarching research interests revolve around solid waste management, utilization of industrial and natural wastes in the development of heterogeneous catalysts, and their further utilization in different industrially viable organic transformations, extraction of various useful metal oxides like silica, alumina from such wastes. I favor interdisciplinary approaches to solve the aforesaid issues and have incorporated synthetic green chemistry as well as material science and conventional organic chemistry approaches in my research. Post Ph.D., I continued my research work at my workplaces in the form of different student projects at college and postgraduate levels. I also describe my interest and activities in science communication. Three of my designed catalysts have been patented on my name, my research work got published in peer-reviewed journals and books, also I presented my results at different international and national conferences. My father was a College Lecturer, so, from the early stages of my life, I want to become a teacher, saying teaching is in my DNA. Stepping to freelance consulting job, I would like to use my novel training as both an organic and environmental chemist, to investigate environmental processes on a range of temporal and spatial scales. I understand being a scientist or researcher does not mean just being successful in research. At the same time, one should be excellent in his/her interactions with the community and the students, in his/her role to lead the academic society, and in responsibilities to transform the community and society. To this end, I have been engaged in several volunteer activities, such as a volunteer in National Service Scheme and Teach For India movement, guiding and encouraging students to apply for further studies, research fellowships, competitive exams.

See Full Profile

Dr. Everson A Nunes, Ph.D.

Hamilton, Ontario, Canada
Post-Doctoral Fellow at McMaster University | former Associate Professor - Physiological Sciences
Most Relevant Research Expertise
Molecular Medicine
Other Research Expertise (39)
skeletal muscle
nutrition
physical activity
obesity
cancer
And 34 more
About
Dr. Everson A Nunes is a highly accomplished researcher and educator in the field of physiological sciences. He received his Ph.D. in Cellular and Molecular Biology with a focus on Physiological Sciences from Universidade Federal do Paraná in 2009, after completing a BSc in Human Nutrition and an MSc in Physiological Sciences. He also holds a specialization in Exercise Physiology and a BSc in Biological Sciences from Universidade Federal do Paraná. Dr. Nunes has a strong background in research, having completed two post-doctoral fellowships at McMaster University and Universidade Federal do Paraná. He has also held positions as an associate professor and assistant professor at Universidade Federal de Santa Catarina. He has published numerous articles in peer-reviewed journals, and his research focuses on the effects of exercise and nutrition on physiological processes in the human body. In addition to his research, Dr. Nunes is also a dedicated educator. He has taught at various universities in Brazil, including Universidade Federal de Santa Catarina, Universidade Gama Filho, Faculdades Integradas Espírita, Pontificia Universidade Católica do Paraná, and Faculdade do Litoral Sul. He is known for his dynamic teaching style and his ability to engage students in complex physiological concepts. Dr. Nunes is a member of several professional organizations, including the American Society for Nutrition, the Canadian Society of Exercise Physiology, the Canadian Nutrition Society and the Brazilian Society of Physiology. He is also a regular speaker at national and international conferences, sharing his expertise and research findings with colleagues and students. Overall, Dr. Nunes is a highly qualified and experienced professional in physiological sciences, metabolism, cancer and nutrition. His dedication to research and education makes him a valuable asset to any institution.
Most Relevant Publications (1+)

97 total publications

Implications of Palmitoleic Acid (Palmitoleate) On Glucose Homeostasis, Insulin Resistance and Diabetes

Current Drug Targets / Mar 30, 2017

Nunes, E., & Rafacho, A. (2017). Implications of Palmitoleic Acid (Palmitoleate) On Glucose Homeostasis, Insulin Resistance and Diabetes. Current Drug Targets, 18(6), 619–628. https://doi.org/10.2174/1389450117666151209120345

See Full Profile

Dr. David Siderovski, Ph.D.

Fort Worth
Professor of Computational Pharmacology; Chair of HSC SBS Dept. of Pharmacology & Neuroscience
Most Relevant Research Expertise
Molecular Medicine
Other Research Expertise (25)
Regulator of G protein Signaling (RGS) proteins
Pharmacology
Molecular Biology
Cellular and Molecular Neuroscience
Cell Biology
And 20 more
About
Dr. David Siderovski is a renowned scientist and academic, with a career spanning over two decades. He received his Ph.D. in Medical Biophysics from the University of Toronto in 1997, where he specialized in signal transduction and cellular signaling pathways. After completing his doctorate, Dr. Siderovski held various faculty positions at prestigious universities, including the University of North Carolina at Chapel Hill, West Virginia University School of Medicine, and the University of North Texas Health Science Center. At these institutions, Dr. Siderovski has made significant contributions to the field of pharmacology through his research on G protein-coupled receptors (GPCRs) and RGS proteins, which are key regulators of GPCR cellular signaling. His work has helped to advance the understanding of RGS proteins and their roles in various diseases, including cancer, cardiovascular disorders, and neurological disorders. In addition to his research, Dr. Siderovski is also a dedicated educator and mentor. He has taught and mentored numerous undergraduate, graduate, and medical students, and has served as a mentor for postdoctoral fellows and junior faculty members. He is known for his passion and enthusiasm for science and his ability to inspire and guide the next generation of scientists. Dr. Siderovski has received numerous awards and honors for his contributions to the scientific community. He was the recipient of the Abel Award in 2004 from the American Society of Pharmacology & Experimental Therapeutics for his pioneering discoveries of the RGS proteins and the GoLoco motif. He has also served on editorial boards of several scientific journals (including a decade at *J.Biol.Chem.*) and has been a member of various scientific committees, NIH study section panels, and pharma/biotech advisory boards, including for Inspire, Wyeth, and BellBrook Labs. Overall, Dr. David Siderovski is a highly accomplished and respected scientist and educator, whose research has had a significant impact on the field of pharmacology. His dedication and passion for science continue to inspire and influence the next generation of researchers in this field.
Most Relevant Publications (8+)

94 total publications

G-protein signaling: back to the future

Cellular and Molecular Life Sciences / Mar 01, 2005

McCudden, C. R., Hains, M. D., Kimple, R. J., Siderovski, D. P., & Willard, F. S. (2005). G-protein signaling: back to the future. Cellular and Molecular Life Sciences, 62(5), 551–577. https://doi.org/10.1007/s00018-004-4462-3

Regulators of G-Protein Signaling and Their Gα Substrates: Promises and Challenges in Their Use as Drug Discovery Targets

Pharmacological Reviews / Jul 07, 2011

Kimple, A. J., Bosch, D. E., Giguère, P. M., & Siderovski, D. P. (2011). Regulators of G-Protein Signaling and Their Gα Substrates: Promises and Challenges in Their Use as Drug Discovery Targets. Pharmacological Reviews, 63(3), 728–749. https://doi.org/10.1124/pr.110.003038

Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights

Molecular Pharmacology / Apr 12, 2007

Johnston, C. A., & Siderovski, D. P. (2007). Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights. Molecular Pharmacology, 72(2), 219–230. https://doi.org/10.1124/mol.107.034348

12/13- and Rho-Dependent Activation of Phospholipase C-ϵ by Lysophosphatidic Acid and Thrombin Receptors

Molecular Pharmacology / Mar 22, 2006

Hains, M. D., Wing, M. R., Maddileti, S., Siderovski, D. P., & Harden, T. K. (2006). Gα12/13- and Rho-Dependent Activation of Phospholipase C-ϵ by Lysophosphatidic Acid and Thrombin Receptors. Molecular Pharmacology, 69(6), 2068–2075. https://doi.org/10.1124/mol.105.017921

The G   DIMER as a NOVEL SOURCE of SELECTIVITY in G-Protein Signaling: GGL-ing AT CONVENTION

Molecular Interventions / Aug 01, 2004

Jones, M. B. (2004). The G   DIMER as a NOVEL SOURCE of SELECTIVITY in G-Protein Signaling: GGL-ing AT CONVENTION. Molecular Interventions, 4(4), 200–214. https://doi.org/10.1124/mi.4.4.4

G protein signaling in the parasite Entamoeba histolytica

Experimental & Molecular Medicine / Mar 22, 2013

Bosch, D. E., & Siderovski, D. P. (2013). G protein signaling in the parasite Entamoeba histolytica. Experimental & Molecular Medicine, 45(3), e15–e15. https://doi.org/10.1038/emm.2013.30

Induction of Regulator of G-Protein Signaling 2 Expression by Long-Acting β2-Adrenoceptor Agonists and Glucocorticoids in Human Airway Epithelial Cells

Journal of Pharmacology and Experimental Therapeutics / Oct 25, 2013

Holden, N. S., George, T., Rider, C. F., Chandrasekhar, A., Shah, S., Kaur, M., Johnson, M., Siderovski, D. P., Leigh, R., Giembycz, M. A., & Newton, R. (2013). Induction of Regulator of G-Protein Signaling 2 Expression by Long-Acting β2-Adrenoceptor Agonists and Glucocorticoids in Human Airway Epithelial Cells. Journal of Pharmacology and Experimental Therapeutics, 348(1), 12–24. https://doi.org/10.1124/jpet.113.204586

The GoLoco Motif: Heralding a New Tango Between G Protein Signaling and Cell Division

Molecular Interventions / Apr 01, 2002

Kimple, R. J. (2002). The GoLoco Motif: Heralding a New Tango Between G Protein Signaling and Cell Division. Molecular Interventions, 2(2), 88–100. https://doi.org/10.1124/mi.2.2.88

See Full Profile

Elvira Forte

New York, New York, United States of America
Scientific strategist • Senior Scientist • Senior Scientific Editor
Most Relevant Research Expertise
Molecular Medicine
Other Research Expertise (26)
fibrosis
inflammation
cardiomyopathies
Physiology
Cardiology and Cardiovascular Medicine
And 21 more
About
Motivated and growth-driven biomedical scientist with over 15 years of experience in the cardiovascular field. Strong background in cell and molecular biology, data analysis, and interpretation. Seeking #newopportunities to deliver value as a Senior Scientist, Associate Principal Scientist, Scientific Liaison, or Scientific Consultant within a company that combines new technologies such as single-cell omics and AI for drug discovery and personalized medicine. <br> Throughout my career, I've used various in vivo and in vitro models to investigate the molecular and cellular mechanisms of fibrosis and inflammation in the heart, and how these mechanisms are affected in mice with different genetic backgrounds. My experience includes project management and mentoring. I completed three projects involving international collaborations, supervised two junior researchers, and taught cellular and molecular techniques to at least six professionals. As one of the launching editors and senior editor at Nature Cardiovascular Research, I oversaw the quality of the content published in the journal and the editorial process. I collaborated with authors, reviewers, and editors to ensure the highest standards of scientific rigor, relevance, and innovation. I also contributed to the journal's vision, strategy, and outreach, promoting the latest advances and discoveries in the cardiovascular and hematology fields. This experience has sharpened my analytical and communication skills and broadened my understanding of the field, covering a wide range of studies, from basic research to clinical, epidemiological, and public health research. My mission is to advance the knowledge and practice of cardiovascular medicine and to bridge the gap between research and clinical applications. Keywords: cardiovascular, #fibrosis, inflammation, cardioimmunology, RNA, single-cell biology, #transcriptomics, imaging, animal models, small animal surgery, and scientific writing.
Most Relevant Publications (6+)

63 total publications

Serum and supplement optimization for EU GMP‐compliance in cardiospheres cell culture

Journal of Cellular and Molecular Medicine / Jan 20, 2014

Chimenti, I., Gaetani, R., Forte, E., Angelini, F., De Falco, E., Zoccai, G. B., Messina, E., Frati, G., & Giacomello, A. (2014). Serum and supplement optimization for <scp>EU GMP</scp>‐compliance in cardiospheres cell culture. Journal of Cellular and Molecular Medicine, 18(4), 624–634. Portico. https://doi.org/10.1111/jcmm.12210

Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application

Journal of Cellular and Molecular Medicine / May 01, 2010

Gaetani, R., Rizzitelli, G., Chimenti, I., Barile, L., Forte, E., Ionta, V., Angelini, F., Sluijter, J. P. G., Barbetta, A., Messina, E., & Frati, G. (2010). Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. Journal of Cellular and Molecular Medicine, no-no. https://doi.org/10.1111/j.1582-4934.2010.01078.x

Different types of cultured human adult Cardiac Progenitor Cells have a high degree of transcriptome similarity

Journal of Cellular and Molecular Medicine / Oct 14, 2014

Gaetani, R., Feyen, D. A. M., Doevendans, P. A., Gremmels, H., Forte, E., Fledderus, J. O., Ramjankhan, F. Z., Messina, E., Sussman, M. A., Giacomello, A., & Sluijter, J. P. G. (2014). Different types of cultured human adult Cardiac Progenitor Cells have a high degree of transcriptome similarity. Journal of Cellular and Molecular Medicine, 18(11), 2147–2151. Portico. https://doi.org/10.1111/jcmm.12458

Bone marrow‐derived cells can acquire cardiac stem cells properties in damaged heart

Journal of Cellular and Molecular Medicine / Jan 01, 2011

Barile, L., Cerisoli, F., Frati, G., Gaetani, R., Chimenti, I., Forte, E., Cassinelli, L., Spinardi, L., Altomare, C., Kizana, E., Giacomello, A., Messina, E., Ottolenghi, S., & Magli, M. C. (2011). Bone marrow‐derived cells can acquire cardiac stem cells properties in damaged heart. Journal of Cellular and Molecular Medicine, 15(1), 63–71. Portico. https://doi.org/10.1111/j.1582-4934.2009.00968.x

A Chemical Biology Approach to Myocardial Regeneration

Journal of Cardiovascular Translational Research / Mar 22, 2011

Willems, E., Lanier, M., Forte, E., Lo, F., Cashman, J., & Mercola, M. (2011). A Chemical Biology Approach to Myocardial Regeneration. Journal of Cardiovascular Translational Research, 4(3), 340–350. https://doi.org/10.1007/s12265-011-9270-6

Type 2 MI induced by a single high dose of isoproterenol in C57BL/6J mice triggers a persistent adaptive immune response against the heart

Journal of Cellular and Molecular Medicine / Nov 29, 2020

Forte, E., Panahi, M., Baxan, N., Ng, F. S., Boyle, J. J., Branca, J., Bedard, O., Hasham, M. G., Benson, L., Harding, S. E., Rosenthal, N., & Sattler, S. (2020). Type 2 MI induced by a single high dose of isoproterenol in C57BL/6J mice triggers a persistent adaptive immune response against the heart. Journal of Cellular and Molecular Medicine, 25(1), 229–243. Portico. https://doi.org/10.1111/jcmm.15937

See Full Profile

Aimee Eggler

Villanova, Pennsylvania, United States of America
Professor of Chemistry and Biochemistry at Villanova University
Most Relevant Research Expertise
Molecular Medicine
Other Research Expertise (18)
Biochemistry
Physiology (medical)
Toxicology
Organic Chemistry
Clinical Biochemistry
And 13 more
About
Dr. Eggler has 20 years of experience in the field of redox biology, with a focus on the Nrf2 transcription factor, a master regulator of antioxidant, detoxification and anti-inflammatory genes. She is also an award-winning educator and the recipient of the Villanova University Junior Faculty Excellence in Teaching award. Her interests in education include innovation in teaching metabolism from a logic-based perspective.
Most Relevant Publications (3+)

25 total publications

Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding

Bioorganic &amp; Medicinal Chemistry Letters / Nov 01, 2013

Turlington, M., Chun, A., Tomar, S., Eggler, A., Grum-Tokars, V., Jacobs, J., Daniels, J. S., Dawson, E., Saldanha, A., Chase, P., Baez-Santos, Y. M., Lindsley, C. W., Hodder, P., Mesecar, A. D., & Stauffer, S. R. (2013). Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding. Bioorganic &amp; Medicinal Chemistry Letters, 23(22), 6172–6177. https://doi.org/10.1016/j.bmcl.2013.08.112

Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease

Journal of Medicinal Chemistry / Jan 03, 2013

Jacobs, J., Grum-Tokars, V., Zhou, Y., Turlington, M., Saldanha, S. A., Chase, P., Eggler, A., Dawson, E. S., Baez-Santos, Y. M., Tomar, S., Mielech, A. M., Baker, S. C., Lindsley, C. W., Hodder, P., Mesecar, A., & Stauffer, S. R. (2013). Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease. Journal of Medicinal Chemistry, 56(2), 534–546. https://doi.org/10.1021/jm301580n

Insecticidal Activity of Cyanohydrin and Monoterpenoid Compounds

Molecules / Apr 03, 2000

Peterson, C., Tsao, R., Eggler, A., & Coats, J. (2000). Insecticidal Activity of Cyanohydrin and Monoterpenoid Compounds. Molecules, 5(12), 648–654. https://doi.org/10.3390/50400648

See Full Profile

Ping Luo

Toronto, Ontario, Canada
Bioinformatics Specialist at Princess Margaret Cancer Centre with experience in deep learning
Most Relevant Research Expertise
Molecular Medicine
Other Research Expertise (21)
single-cell genomics
deep learning
complex network analysis
Genetics (clinical)
Genetics
And 16 more
About
8 years of science and engineering experience integrating multi-omics data to identify biomarkers for cancer studies. Seeking to apply data analytics expertise to develop new diagnosis and treatment strategies.
Most Relevant Publications (2+)

23 total publications

deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks

Frontiers in Genetics / Jan 29, 2019

Luo, P., Ding, Y., Lei, X., & Wu, F.-X. (2019). deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks. Frontiers in Genetics, 10. https://doi.org/10.3389/fgene.2019.00013

Identifying Disease-Gene Associations With Graph-Regularized Manifold Learning

Frontiers in Genetics / Apr 02, 2019

Luo, P., Xiao, Q., Wei, P.-J., Liao, B., & Wu, F.-X. (2019). Identifying Disease-Gene Associations With Graph-Regularized Manifold Learning. Frontiers in Genetics, 10. https://doi.org/10.3389/fgene.2019.00270

See Full Profile

Garrett A. Perchetti, Research Scientist - Virology

New York
Research Scientist and MD Candidate in virology with publications on infectious diseases, laboratory medicine, viral genetics, and clinical medicine
Most Relevant Research Expertise
Molecular Medicine
Other Research Expertise (14)
Virology
Microbiology
Infectious Diseases
SARS-CoV-2
COVID-19
And 9 more
About
Garrett A. Perchetti is a highly accomplished research scientist in the field of virology. He received a Bachelor of Science in Microbiology and a Bachelor of Arts in Art History from the University of Washington. His interest in both science and the arts led him to pursue a career in virology, where he could combine his passion for understanding the natural world with his creative thinking skills. After completing his undergraduate studies, Garrett continued his education by earning a Medical Degree from Ross University School of Medicine in 2025. During his time in medical school, he developed a keen interest in virology and infectious diseases, which ultimately led him to specialize in this field. Garrett's educational background is complemented by his extensive experience as a research scientist. He has worked at the University of Washington School of Medicine, where he has conducted groundbreaking research on various types of viruses. His work has been published in numerous scientific journals, and he has presented his findings at international conferences. Garrett's contributions to the field of virology have been widely recognized, and he has received several awards and accolades for his work. He is known for his meticulous attention to detail, innovative thinking, and ability to collaborate effectively with other researchers. In his free time, Garrett enjoys painting, hiking, and traveling. He is also passionate about raising awareness about the importance of vaccinations and promoting public health initiatives. With his exceptional education and extensive experience, Garrett A. Perchetti is a valuable asset to the field of virology and will continue to make significant contributions in the future.
Most Relevant Publications (1+)

28 total publications

Predicting infectivity: comparing four PCR‐based assays to detect culturable SARS‐CoV‐2 in clinical samples

EMBO Molecular Medicine / Dec 13, 2021

Bruce, E. A., Mills, M. G., Sampoleo, R., Perchetti, G. A., Huang, M., Despres, H. W., Schmidt, M. M., Roychoudhury, P., Shirley, D. J., Jerome, K. R., Greninger, A. L., & Botten, J. W. (2021). Predicting infectivity: comparing four PCR‐based assays to detect culturable SARS‐CoV‐2 in clinical samples. EMBO Molecular Medicine, 14(2). Portico. https://doi.org/10.15252/emmm.202115290

See Full Profile

Example Molecular Medicine projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Molecular Medicine?

Drug Discovery and Development

A pharmaceutical company can collaborate with a Molecular Medicine expert to identify potential drug targets, design and optimize drug candidates, and conduct preclinical and clinical trials. This collaboration can significantly speed up the drug discovery and development process, leading to the creation of novel and effective therapies.

Personalized Medicine

By working with a Molecular Medicine researcher, a healthcare company can develop personalized treatment strategies based on an individual's genetic makeup, lifestyle, and environmental factors. This approach can improve patient outcomes, minimize adverse effects, and optimize healthcare resources.

Genomics and Precision Medicine

Companies in the biotechnology and diagnostics sectors can collaborate with Molecular Medicine experts to leverage genomic data for disease diagnosis, prognosis, and treatment selection. This collaboration can lead to the development of innovative diagnostic tools, targeted therapies, and precision medicine approaches.

Biomarker Identification

A company focused on biomarker discovery can benefit from collaborating with a Molecular Medicine expert. These researchers can identify and validate biomarkers that can be used for early disease detection, monitoring treatment response, and predicting patient outcomes. Such collaborations can drive the development of diagnostic tests and personalized medicine solutions.

Therapeutic Interventions

Pharmaceutical and biotechnology companies can partner with Molecular Medicine experts to explore novel therapeutic interventions, including gene therapies, RNA-based therapeutics, and targeted drug delivery systems. These collaborations can lead to the development of breakthrough treatments for various diseases and conditions.